Elsea S H, Fritz E, Schoener-Scott R, Meyn M S, Patel P I
Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.
Am J Med Genet. 1998 Jan 6;75(1):104-8.
Smith-Magenis syndrome (SMS) is caused by an interstitial deletion of chromosome band 17p11.2 averaging 4-5 Mb. This deletion is likely to contain a large number of genes, each of which could potentially contribute toward the clinical phenotype. We report that the gene for topoisomerase III (hTOP3) is commonly deleted in SMS patients and maps between D17S447 and D17S258 on the short arm of chromosome 17. Cellular studies of SMS patient lymphoblasts and their respective parental cell lines were undertaken to determine the consequences of haploinsufficiency of hTOP3. Our studies indicate that hemizygosity for hTOP3 does not appreciably affect cell-cycle kinetics or activation of ionizing radiation-sensitive cell-cycle checkpoints. Furthermore, the induction of apoptosis in response to ionizing radiation in SMS and parental cells was similar. Our studies suggest that haploinsufficiency of hTOP3 does not have a major impact on the behavior of cells from SMS patients and may not play a significant role in the SMS phenotype.
史密斯-马吉尼斯综合征(SMS)是由17号染色体17p11.2带的间质性缺失引起的,平均缺失4-5兆碱基对。这种缺失可能包含大量基因,每个基因都可能对临床表型有潜在影响。我们报告,拓扑异构酶III(hTOP3)基因在SMS患者中通常缺失,并且定位于17号染色体短臂上的D17S447和D17S258之间。对SMS患者淋巴母细胞及其各自的亲本细胞系进行了细胞研究,以确定hTOP3单倍剂量不足的后果。我们的研究表明,hTOP3的半合子状态不会明显影响细胞周期动力学或电离辐射敏感的细胞周期检查点的激活。此外,SMS细胞和亲本细胞对电离辐射诱导的凋亡情况相似。我们的研究表明,hTOP3单倍剂量不足对SMS患者细胞的行为没有重大影响,可能在SMS表型中不发挥重要作用。